Newstral
Article
Seattle Times on 2021-11-12 23:07
Alzheimer’s drug cited as Medicare premium jumps by $21.60
Related news
- Biogen's Alzheimer's drug cited as Medicare premium jumps by $21.60WRAL
- Alzheimer’s drug cited as Medicare premium jumps by $21.60pressherald.com
- Alzheimer’s drug cited as Medicare premium jumps by $21.60 monthlypressherald.com
- Alzheimer's drug cited as Medicare premium jumps by $21.60 - Fri, 12 Nov 2021 PSTThe Spokesman-Review
- Medicare told to reassess premium hike for Alzheimer’s drugjournalrecord.com
- Medicare weighs premium cut after limiting Alzheimer’s drugSeattle Times
- Medicare copays for new Alzheimer’s drug could reach $11,500Seattle Times
- Medicare will limit coverage of pricey Alzheimer’s drugSan Jose Mercury News
- Big premium increases foreseen for Medicare drug planKHQ Local News